LEXICON PHARMACEUTICALS, INC.

LXRX · Nasdaq · SIC 2834: Pharmaceutical Preparations
301
SEC Filings

Business Summary

Overview We are a biopharmaceutical company with a mission of pioneering medicines that transform patients lives. We are devoting most of our resources to the research and development of our most advanced drug candidates and the commercialization of our approved drug, INPEFA (sotagliflozin): We are developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for hypertrophic cardiomyopathy, or HCM, and are conducting the SONATA-HCM pivotal Phase 3 clinical trial of...

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionLXRXdiscussed_in_filing Cybersecurity
topic_mentionLXRXdiscussed_in_filing Trusted Computing
topic_mentionLXRXdiscussed_in_filing Blockchain & Crypto
topic_mentionLXRXdiscussed_in_filing Regulation
topic_mentionLXRXdiscussed_in_filing Healthcare & Bio
topic_mentionLXRXdiscussed_in_filing Platform & Ecosystem
topic_mentionLXRXdiscussed_in_filing Sovereign & Government
topic_mentionLXRXdiscussed_in_filing Cybersecurity
topic_mentionLXRXdiscussed_in_filing Trusted Computing
topic_mentionLXRXdiscussed_in_filing Blockchain & Crypto
topic_mentionLXRXdiscussed_in_filing Regulation
topic_mentionLXRXdiscussed_in_filing Healthcare & Bio
topic_mentionLXRXdiscussed_in_filing Platform & Ecosystem
topic_mentionLXRXdiscussed_in_filing Sovereign & Government
topic_mentionLXRXdiscussed_in_filing Cybersecurity
topic_mentionLXRXdiscussed_in_filing Trusted Computing
topic_mentionLXRXdiscussed_in_filing Blockchain & Crypto
topic_mentionLXRXdiscussed_in_filing Regulation
topic_mentionLXRXdiscussed_in_filing Healthcare & Bio
topic_mentionLXRXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001062822-26-000050EDGAR49K words
2025-03-072024-12-310001062822-25-000013EDGAR—
2024-03-252023-12-310001062822-24-000008EDGAR—
2023-03-032022-12-310001062822-23-000007EDGAR—
2022-03-102021-12-310001062822-22-000005EDGAR—
2021-03-122020-12-310001062822-21-000013EDGAR—
2020-03-122019-12-310001062822-20-000015EDGAR—
2019-03-152018-12-310001062822-19-000007EDGAR—
2018-03-012017-12-310001062822-18-000008EDGAR—
2017-03-062016-12-310001062822-17-000013EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001062822-25-000054EDGAR14K words
2025-08-062025-06-300001628280-25-038340EDGAR—
2025-05-142025-03-310001062822-25-000029EDGAR—
2024-11-132024-09-300001062822-24-000060EDGAR—
2024-08-022024-06-300001062822-24-000046EDGAR—
2024-05-022024-03-310001062822-24-000024EDGAR—
2023-11-082023-09-300001062822-23-000058EDGAR—
2023-08-042023-06-300001062822-23-000047EDGAR—
2023-05-042023-03-310001062822-23-000024EDGAR—
2022-11-092022-09-300001062822-22-000042EDGAR—
2022-08-032022-06-300001062822-22-000035EDGAR—
2022-05-052022-03-310001062822-22-000022EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001062822-26-000047EDGAR2K words
2026-02-020001193125-26-033793EDGAR—
2026-01-290001193125-26-029514EDGAR—
2025-11-100001193125-25-274383EDGAR—
2025-11-060001193125-25-270020EDGAR—
2025-11-060001062822-25-000049EDGAR—
2025-08-060001062822-25-000042EDGAR—
2025-07-280001062822-25-000037EDGAR—
2025-07-030001062822-25-000035EDGAR—
2025-06-030001062822-25-000033EDGAR—

301 total filings indexed. 269 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001062822
TickerLXRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e4cd7a4efc940080e0faab0d7047df779343373aa69872690bfe717473f2f243
parent: f8b11cb7eb7a5d1b0d929cdecbfe5705b5b31ac831d561b07bb48dae5a35ada0
content hash: 3deb2de4ca7ff0dfc7ed9cca19993f5479599711a85d050e677601734d2feb5d
signed: 2026-04-13T04:46:08.460Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf